MAPT and Alzheimer disease: For genetically complex diseases such as AD, PRSs have been shown to strengthen AD diagnostic classification beyond the use of APOE genotypes (9) and have further been shown to be associated with brain structure, Aβ and tau pathology, and cognitive decline (10–13).